Alpha 2.0
Login Register
» Authors » C Gonzalez-Velasco

C Gonzalez-Velasco

Explore the profile of C Gonzalez-Velasco including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 16
Followers 0
Related Specialties
Pharmacology
Microbiology
Infectious Diseases
Top 10 Co-Authors
A C Gomez-Garcia
M T Blanco
C Perez-Giraldo
M Gonzalez-Velasco
C Hurtado
J J Moreno
A Vindel
V Aguadero
F J Moran
M Gonzalez
Published In
Rev Esp Quimioter
Med Mycol
Euro Surveill
Chemotherapy
Eur J Clin Microbiol Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
An analysis of the association between genotype and antimicrobial resistance in methicillin-resistant Staphylococcus aureus clinical isolates
Aguadero V, Gonzalez-Velasco C, Vindel A, Gonzalez-Velasco M, Moreno J
Rev Esp Quimioter . 2015 Apr; 28(2):79-85. PMID: 25904514
Genotyping methods are useful resources for the surveillance, detection, prevention and control of multidrug-resistant nosocomial agents, such as methicillin-resistant Staphylococcus aureus (MRSA). An understanding of the association between genotype and...
2.
[State of infection caused by methicillin-resistant Staphylococcus aureus (MRSA) in Extremadura: susceptibility, clonality and role of community-associated MRSA]
Aguadero V, Gonzalez-Velasco C, Vindel A, Gonzalez-Velasco M, Moreno J
Rev Esp Quimioter . 2014 Sep; 27(3):180-9. PMID: 25229373
The correct surveillance and control of infection caused by methicillin-resistant Staphylococcus aureus (MRSA) needs of update knowledge of its specific properties in each place. Our study aims to describe the...
3.
Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors
Perez-Sautu U, Pozo F, Cuesta I, Monzon S, Calderon A, Gonzalez M, et al.
Euro Surveill . 2014 Jul; 19(27):14-20. PMID: 25033052
The Y155H amino acid substitution in the neuraminidase gene (NA) has previously been associated with highly reduced inhibition by neuraminidase inhibitors in the seasonal H1N1 influenza A virus which circulated...
4.
Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution
Monterrubio-Villar J, Gonzalez-Velasco C, Valdezate-Ramos S, Cordoba-Lopez A, Villalon-Panzano P, Saez-Nieto J
Eur J Clin Microbiol Infect Dis . 2009 Jul; 28(10):1281-4. PMID: 19639350
An outbreak of multidrug-resistant Acinetobacter baumannii (MRAB) occurred over the course of a 27-week period in our adult polyvalent intensive care unit (ICU). Twenty-one patients were affected, and 72 strains...
5.
Moxifloxacin and biofilm production by coagulase-negative staphylococci
Perez-Giraldo C, Gonzalez-Velasco C, Sanchez-Silos R, Hurtado C, Blanco M, Gomez-Garcia A
Chemotherapy . 2004 Jun; 50(2):101-4. PMID: 15211086
The in vitro activity of moxifloxacin against 41 strains of coagulase-negative staphylococci was determined. A relationship between the activity of moxifloxacin and biofilm formation was detected. Biofilm-producing strains were more...
6.
Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases
Blanco M, Hurtado C, Perez-Giraldo C, Moran F, Gonzalez-Velasco C, Gomez-Garcia A
Med Mycol . 2003 Sep; 41(2):167-70. PMID: 12964850
An in vitro study to evaluate the antifungal effect and activity of aspartyl proteinases of the HIV-proteinase inhibitors ritonavir and saquinavir was conducted. Ritonavir diminished the growth rate of Candida...